Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2025-12-26 @ 2:55 AM
Study NCT ID:
NCT00050102
Status:
COMPLETED
Last Update Posted:
2011-01-28
First Post:
2002-11-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-10
Start Date Type:
None
Primary Completion Date:
2004-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-02
Completion Date Type:
ACTUAL
First Submit Date:
2002-11-21
First Submit QC Date:
None
Study First Post Date:
2002-11-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-01-28
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2011-01-20
Last Update Post Date:
2011-01-28
Last Update Post Date Type:
ESTIMATED